Product Title:Â Handbook of Cancer Chemotherapy, 8th Edition (ORIGINAL PDF from Publisher)
Format:
RETAIL PDF, ToC, Index, Full Bookmark,
Overview (Details, Topics and Speakers):
by Roland T. Skeel, Samir Khleif
The fourth edition of Handbook of Cancer Chemotherapy provides an up-to-date guide to all aspects of chemotherapyincluding the safe administration of chemotherapeutic agents and the rationale for chemotherapy – whether administered alone or in conjunction with surgery, radiation, or immunotherapy. In an easy-to-follow outline format, Handbook of Cancer Chemotherapy, Fourth Edition, provides comprehensive coverage of basic principles and considerations of rational chemotherapy, chemotherapeutic and biologic agents, chemotherapy of human cancer and selected aspects of supportive care of patients with cancer. The latest edition of this thoroughly revised practical handbook also introduces new chapters on high-dose chemotherapy and the role of progenitor cell and cytokine support; quality-of-life considerations and cost-utility assessments in cancer treatment decisions and issues of cancer survivorship: insurance, employment, and psychosocial factors. Concise and easy to use, Handbook of Cancer Chemotherapy, Fourth Edition, is a logically organized reference for internists, hematologists, oncologists, primary care physicians, and oncology nurses who want the most accurate and up-to-date information for management of their patients with cancer.
The book contains no figures.
Product Details
- ISBN-13: 9781608317820
- Publisher: Lippincott Williams & Wilkins
- Publication date: 5/18/2011
- Series: Lippincott Williams & Wilkins Handbook Series
- Edition description: Eighth
- Edition number: 8
- Pages: 832
Delivery Method
the Handbook of Cancer Chemotherapy, 8th Edition (ORIGINAL PDF from Publisher) course/book will be provided for customer as download link. download link has NO Expiry and can be used anytime.
Contact Us
contact us to our email at [email protected] or fill in the form below:
Reviews
There are no reviews yet.